Sen. Bill Cassidy canceled a November 18 committee vote to advance President Donald Trump’s nomination of Jim O’Neill to lead the National Science Foundation. O’Neill “didn’t have the votes,” the Louisiana Republican told Science after the meeting. Source
“I like Jim personally, but this job requires leadership and fortitude in standing up for what is right,” Cassidy said in his opening statement, according to Science. The personal compliment came with a rather large professional objection. Source
This was a canceled vote in the Senate Health, Education, Labor and Pensions Committee, which Cassidy chairs—not a formal rejection by the full Senate. POLITICO reported that it remained unclear whether O’Neill’s nomination had been withdrawn or the vote simply postponed. Source Source
Cassidy questions O’Neill’s independence
O’Neill, a financier and former deputy secretary of Health and Human Services, served as acting director of the Centers for Disease Control and Prevention after Susan Monarez was fired in 2025. Source
Cassidy said O’Neill “did not do enough to stand up for science,” criticizing his response to decisions and statements by Health and Human Services Secretary Robert F. Kennedy Jr., Science reported. Source
“His role in the firing of Dr. Susan Monarez raised further concerns about the independent judgment he would bring to NSF,” Cassidy said, according to Scientific American. Monarez has attributed her dismissal to refusing to approve vaccine recommendations that lacked evidence or to fire employees without cause. Source
Democratic senators and scientific organizations had also sought a confirmation hearing before the committee considered O’Neill. POLITICO reports that he would have been NSF’s first director without a scientific or engineering background. Source Source
Two nominations stumble, with different outcomes
The White House withdrew Heidi Overton’s nomination to lead the Food and Drug Administration on November 17, a day before O’Neill’s vote was canceled. Cassidy disputed the administration’s assessment of her support, saying she had a viable confirmation path. Source
Cassidy told POLITICO that confirming an FDA replacement before Democrats take control of the Senate in January would be very difficult. Source
Meanwhile, NSF has lacked a permanent director since April 2025, when Sethuraman Panchanathan resigned, Science reports. Brian Stone, who has been heading the agency in the meantime, plans to leave government at the end of 2026. Blocking a disputed nominee doesn’t fill that leadership gap. Source
Comments